Static DNA Nanostructures For Cancer Theranostics: Recent Progress In Design And Applications
Open accessThe DOI matches its Crossref record; 170 of the 173 references it cites were found in a registry or an index.
Abstract
Among the various nano/biomaterials used in cancer treatment, the beauty and benefits of DNA nanocomposites are outstanding. The specificity and programmability of the base pairing of DNA strands, together with their ability to conjugate with different types of functionalities have realized unsurpassed potential for the production of two- and three-dimensional nano-sized structures in any shape, size, surface chemistry and functionality. This review aims to provide an insight into the diversity of static DNA nanodevices, including DNA origami, DNA polyhedra, DNA origami arrays and bioreactors, DNA nanoswitch, DNA nanoflower, hydrogel and dendrimer as young but promising platforms for cancer theranostics. The utility and potential of the individual formats in biomedical science and especially in cancer therapy will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that CTCs can be used as diagnostic tools providing molecular information on the primary tumor state”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [155]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the development of liquid biopsy platforms capable of capturing this rare population of cells from the blood is highly rewarding [155].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Folding DNA to create nanoscale shapes and patterns
Rothemund, P. W. K. (2006) · Nature · doi:10.1038/nature04586 · Cited by 7,354
Seeman, N. C. (2003) · Nature · doi:10.1038/nature01406 · Cited by 2,782 · cited 1×
“NF formation increased steric hindrance in the channels, which reduced the anodic current of potassium ferricyanide (K3[Fe(CN)6]), thus producing enhanced electrochemical detection signals (Figure 5A).”
A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads
Douglas, S. M., Bachelet, I., & Church, G. M. (2012) · Science · doi:10.1126/science.1214081 · Cited by 2,180
Hydrogels: From controlled release to pH-responsive drug delivery
Gupta, P., Vermani, K., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02255-9 · Cited by 1,825 · cited 2×
“147 Different types of DNA building blocks can be used to produce these hydrogels, including single-stranded DNA branched double-stranded DNA, or Y-shaped DNA or X-shaped DNA through intermolecular i-motif structures, enzyme ligation, DNA hybridization, or enzyme polymerization.”
Ammonia Clathrate Hydrate As Seen from Grand Canonical Monte Carlo Simulations
Fábián, B., Picaud, S., Jedlovszky, P., Guilbert-Lepoutre, A., & Mousis, O. (2018) · ACS Earth and Space Chemistry · doi:10.1021/acsearthspacechem.7b00133 · Cited by 1,699
Folding DNA into Twisted and Curved Nanoscale Shapes
Dietz, H., Douglas, S. M., & Shih, W. M. (2009) · Science · doi:10.1126/science.1174251 · Cited by 1,335
DNA Origami with Complex Curvatures in Three-Dimensional Space
Han, D., Pal, S., Nangreave, J., Deng, Z., Liu, Y., & Yan, H. (2011) · Science · doi:10.1126/science.1202998 · Cited by 1,214
Drug Delivery with PEGylated MoS2 Nano‐sheets for Combined Photothermal and Chemotherapy of Cancer
Liu, T., Wang, C., Gu, X., Gong, H., Cheng, L., Shi, X., Feng, L., Sun, B., & Liu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201305256 · Cited by 1,211
Protein–inorganic hybrid nanoflowers
Ge, J., Lei, J., & Zare, R. N. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.80 · Cited by 1,200
Research works printed but not linked: 3
- [124]Lee H, Lytton-Jean AKR, Chen Y, et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol. 2012; 7: 389. doi: 10.1038/nnano.2012.73 22659608 PMC3898745 · DOI · Paper page
- [153]Shahbazi M-A, Bauleth-Ramos T, Santos HA. Hydrogel Assemblies: DNA Bridging synthesis principles to biomedical applications. 2018; 1(4): 1800042.
- [157]Park N, Um SH, Funabashi H, Xu J, Luo D. A cell-free protein-producing gel. Nat Mater. 2009; 8(5): 432– 437. doi: 10.1038/nmat2419 19329993 · DOI · Paper page
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Given that CTCs can be used as diagnostic tools providing molecular information on the primary tumor state, the development of liquid biopsy platforms capable of capturing this rare population of cells from the blood is highly rewarding [155] .”
BackgroundSelf-citationAyoubi‐Joshaghani, M. H., Seidi, K., Azizi, M., Jaymand, M., Javaheri, T., Jahanban‐Esfahlan, R., & Hamblin, M. R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004098 · Cited by 137
Self-citationNano-Therapies for Glioblastoma Treatment
Alphandéry, E. (2020) · Cancers · doi:10.3390/cancers12010242 · Cited by 126
Stevanović, M. M., & Filipović, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050670 · Cited by 106
Advanced Bioresponsive Multitasking Hydrogels in the New Era of Biomedicine
Niazi, M., Alizadeh, E., Zarebkohan, A., Seidi, K., Ayoubi‐Joshaghani, M. H., Azizi, M., Dadashi, H., Mahmudi, H., Javaheri, T., Jaymand, M., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104123 · Cited by 89
Self-citationAptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging
Liu, M., Wang, L., Lo, Y., Shiu, S. C., Kinghorn, A. B., & Tanner, J. A. (2022) · Cells · doi:10.3390/cells11010159 · Cited by 100
“Similarly, a DNA dendritic nanostructure composed of three aptamers was designed for targeted and controlled delivery of anti-tumor drug epirubicin to cancer cells [73].”
BackgroundA rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores
Kim, H.-S., Abbas, N., & Shin, S. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113005 · Cited by 77
Bioinspired hydrogels build a bridge from bench to bedside
Seidi, K., Ayoubi‐Joshaghani, M. H., Azizi, M., Javaheri, T., Jaymand, M., Alizadeh, E., Webster, T. J., Ahmadieh-Yazdi, A., Niazi, M., Hamblin, M. R., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101157 · Cited by 62
Self-citationDynamic DNA nanostructures in biomedicine: Beauty, utility and limits
Jahanban-Esfahlan, A., Seidi, K., Jaymand, M., Schmidt, T. L., Majdi, H. S., Javaheri, T., Jahanban‐Esfahlan, R., & Zare, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.003 · Cited by 58
Self-citationAptamer-engineered (nano)materials for theranostic applications
Rabiee, N., Chen, S., Ahmadi, S., & Veedu, R. N. (2023) · Theranostics · doi:10.7150/thno.85419 · Cited by 59
“As a result, modified DNA structures with theranostic moieties were applied for the targeting of different immunological, cancer, and metabolic diseases [75, 76].”
Ayoubi‐Joshaghani, M. H., Dianat‐Moghadam, H., Seidi, K., Jahanban‐Esfahalan, A., Zare, P., & Jahanban‐Esfahlan, R. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27248 · Cited by 52
Self-citationNano‐biotechnology in tumour and cancerous disease: A perspective review
Soni, A., Bhandari, M. P., Tripathi, G. K., Bundela, P., Khiriya, P. K., Khare, P. S., Kashyap, M. K., Dey, A., Vellingiri, B., Suresh, S., et al. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17677 · Cited by 53
Regeneration of Burnt Bridges on a DNA Catenane Walker
Valero, J., & Famulok, M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004447 · Cited by 49
Moradi, S., Najjar, R., Hamishehkar, H., & Lotfi, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103426 · Cited by 49
Self-citationZhao, D., Liu, M., Li, J., Xiao, D., Peng, S., He, Q. P., Sun, Y., Li, Q., & Lin, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c08565 · Cited by 49
Functionalized DNA nanostructures for bioimaging
Shaikh, S. A., Younis, M., & Yuan, L. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214648 · Cited by 46
Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities
Mehrgou, A., Ebadollahi, S., Seidi, K., Ayoubi‐Joshaghani, M. H., Ahmadieh-Yazdi, A., Zare, P., Jaymand, M., & Jahanban‐Esfahlan, R. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2021.029 · Cited by 35
Self-citationAptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics
Walia, S., Chandrasekaran, A. R., Chakraborty, B., & Bhatia, D. D. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00413 · Cited by 33
Smart Drug Delivery Systems Based on DNA Nanotechnology
Fan, Q., He, Z., Xiong, J., & Chao, J. (2022) · ChemPlusChem · doi:10.1002/cplu.202100548 · Cited by 33
Jabbari, A., Sameiyan, E., Yaghoobi, E., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123448 · Cited by 30
Functionalized-DNA nanostructures as potential targeted drug delivery systems for cancer therapy
Kumar, A., Ahmad, A., Ansari, M. M., Gowd, V., Rashid, S., Chaudhary, A. A., Rudayni, H. A., Alsalamah, S. A., & Khan, R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.003 · Cited by 23
Remotely-controlled hydrogel platforms for recurrent cancer therapy
Dadashi, H., Eskandani, M., Roshangar, L., Sharifi-Azad, M., Shahpouri, M., Cho, W. C. S., & Jahanban‐Esfahlan, R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104354 · Cited by 25
Self-citationInsights into Multifunctional Nanoparticle-Based Drug Delivery Systems for Glioblastoma Treatment
Khan, M. W. A., Sherwani, S., Khan, S. A., Alouffi, S., Alam, M. J., Al-Motair, K. A., & Khan, S. N. (2021) · Molecules · doi:10.3390/molecules26082262 · Cited by 22
“In light of this, several research studies were conducted to examine different NPs (polymers, liposomes, molecules, proteins and nucleic acids) which showed optimal outcomes with increasing efficacy and reduced toxicity [10,13].”
BackgroundInfluentialNavaneeth, A. G., & Karthikeyan, S. (2024) · RSC Pharmaceutics · doi:10.1039/d3pm00027c · Cited by 20
Panda, P., Kar, S. S., & Mohapatra, R. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100336 · Cited by 16
Biodistribution and function of coupled polymer-DNA origami nanostructures
Joseph, N., Shapiro, A., Gillis, E., Barkey, S., Abu-Horowitz, A., Bachelet, I., & Mizrahi, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-46351-1 · Cited by 19
Kumari, K., Kar, A., Nayak, A. K., Mishra, S. K., & Subudhi, U. (2021) · RSC Advances · doi:10.1039/d0ra10733f · Cited by 13
Engineered Niosomes for Cancer Therapy: Classification, Synthesis, and Clinical Applications
Hashemi, Z., Beheshtizadeh, N., Jaymand, M., Jahanban‐Esfahlan, A., Akbari, M., & Jahanban‐Esfahlan, R. (2024) · BioNanoScience · doi:10.1007/s12668-024-01647-y · Cited by 16
Self-citationAlamolhoda, S. Z., Zarghami, N., Kahroba, H., Mehdipour, A., Pourhassan‐Moghaddam, M., Jahanban‐Esfahlan, R., & Milani, M. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.004 · Cited by 17
Self-citationZenjanab, M. K., Salemi, A., Doustmihan, A., Alimohammadvand, S., & Jahanban‐Esfahlan, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-14704-7 · Cited by 13
“Lipid-based NPs (liposomes 18 , niosomes 19 ), micells 20 , non-organic NPs 21,22 , hydrogels 23–27 , chitosan 1,28–30 , DNA nanostructure 31,32 and dendrimers 33,34 are some examples of nanosystems used for therapeutic purposes.”
Self-citationKar, A., Kumari, K., Mishra, S. K., & Subudhi, U. (2022) · BMC Cancer · doi:10.1186/s12885-022-10423-8 · Cited by 10
Faraji-Barhagh, A., Jahandar-Lashaki, S., Jahanban‐Esfahlan, R., & Alizadeh, E. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10462-x · Cited by 9
“…are employed in NDDSs for targeted cancer therapy, including hydrogels [18–20], liposomes [21], niosomes [12, 22–24], DNA nanostructure [25, 26], polymeric NPs [27–29], inorganic NPs (such as gold and iron oxide) [30–33], metal organic framework NPs [34], carbon-based NPs (such as graphene…”
Self-citationRegeneration of Burnt Bridges on a DNA Catenane Walker
Valero, J., & Famulok, M. (2020) · Angewandte Chemie · doi:10.1002/ange.202004447 · Cited by 6
Gupta, U., Kosey, S., & Pal, R. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107181 · Cited by 13
Non-cationic carriers for siRNA delivery: Current progress and potential applications
Fan, M., Yang, X., Liu, Y., Xia, X., Ismail, M., & Zheng, M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114362 · Cited by 6
Aptamer-based theranostic approaches for treatment of cancer
Shahriari, M., Kesharwani, P., & Sahebkar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00016-6 · Cited by 5
Nam, H., Kim, T., Moon, S., Ji, Y., & Lee, J. B. (2023) · iScience · doi:10.1016/j.isci.2023.107089 · Cited by 5
“loading of gene templates via enzymatic self-assembly, hybridization with sticky ends,(27) and modification of chemical linker.(28) For this reason, the Luo research group has developed a solid-phase protein production system using DNA hydrogels.”
Emerging Approaches to Brain Cancer Treatment: A Review of Targeting Modalities
Garg, N., & Dewangan, H. K. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128385127250828160927 · Cited by 3
Drug discovery efforts at George Mason University
Andalibi, A., Veneziano, R., Paige, M. A., Buschmann, M. D., Haymond, A. N., Espina, V. A., Luchini, A., Liotta, L. A., Bishop, B., & van Hoek, M. L. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.03.001 · Cited by 2
Kar, A., Kumari, K., Mishra, S. K., & Subudhi, U. (2022) · Research Square · doi:10.21203/rs.3.rs-1464868/v1 · Cited by 1
Static DNA Nanostructures and Their Applications
Bhattacharya, D. (2022) · Wiley eBooks · doi:10.1002/9781119857747.ch8 · Cited by 1
Kar, A., Kumari, K., Mishra, S. K., & Subudhi, U. (2022) · Research Square · doi:10.21203/rs.3.rs-1464868/v2
Functional Magnetic Solid Lipid Nanoparticles for Theranostic Applications
Raut, S. Y., Vitore, J. G., Alandikar, P., Singh, S., Jadhav, R., Benival, D. M., & Giram, P. S. (2024) · Wiley eBooks · doi:10.1002/9781394172917.ch7
Microfluidics in protein engineering
Patra, S., Karpe, Y. A., & Gajbhiye, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95533-1.00014-x · Cited by 1
Haymanalı, D. N. (2025) · IEEE Nanotechnology Materials and Devices Conference (NMDC) · doi:10.1109/nmdc64551.2025.11234556
“MDR leads to increased drug efflux, enhanced DNA repair mechanisms, and altered cellular uptake (6), all of which reduce the effectiveness of treatment.”
Kar, A., Kumari, K., Mishra, S. K., & Subudhi, U. (2023) · Figshare · doi:10.6084/m9.figshare.22607750
Azo-based compounds for hypoxia-responsive drug delivery
Nasiri, S., & Najjar, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00015-4
Self-citationCell Surface Engineering with DNA Nanotechnology: From Molecular Design to Biological Application
Xiong, M., Xie, Y., Li, N., & Ding, B. (2026) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6c04154
Alibaglou, M. H., Chaharlashkar, Z., Bina, F., Jaymand, M., Liu, G., & Jahanban‐Esfahlan, R. (2026) · BioNanoScience · doi:10.1007/s12668-026-02783-3
“Furthermore, integration with functional nanomaterials, including platinum nanoparticles (Pt NPs), TiO₂@Ag nanozymes, and nanowires, has further enhanced electrochemical and elec-trochemiluminescent signal transduction, improving analytical sensitivity and specificity [ 59–63].”
Self-citationRezaee, D., Alipourfard, I., & Noori-Zadeh, A. (2026) · BioNanoScience · doi:10.1007/s12668-026-02833-w · Cited by 1
Metadata
- Authors
- Jahanban-Esfahlan, R., Seidi, K., Jahanban-Esfahlan, A., Jaymand, M., Alizadeh, E., Majdi, H., Najjar, R., Javaheri, T., & Zare, P.
- Affiliations
- Tabriz University of Medical Sciences (IR)
- Kermanshah University of Medical Sciences (IR)
- University of Tabriz (IR)
- Ludwig Boltzmann Institute for Cancer Research (AT)
- Corresponding author
- Javaheri, Tahereh
- Venue
- Nanotechnology, Science and Applications
- Publisher
- Informa UK Limited
- Published
- 2019-10
- Volume
- Volume 12
- Pages
- 25-46
- ISSN
- 1177-8903 (ISSN-L)
- PMC
- PMC6800557
- OpenAlex
- W2979491937
- Cited by
- 50
- References
- 173
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 6 · 2019: 2
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nanotechnology Science and Applications (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Uniwersytet Kardynała Stefana Wyszyńskiego w Warszawie
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- DNA nanotechnology, cancer theranostics, DNA origami, DNA nanoswitches, DNA nanoflowers, DNA hydrogels, DNA dendrimers, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.